effects chlorophyll chlorophyllin low-dose aflatoxin num pharmacokinetics human volunteers pubmed ncbi abstract chlorophyll chla chlorophyllin chl shown previously reduce carcinogen bioavailability biomarker damage tumorigenicity trout rats findings partially extended humans chl reduced excretion aflatoxin num afb num dna repair products chinese unavoidably exposed dietary afb num afb num pharmacokinetics chla effects examined conducted unblinded crossover study establish afb num pharmacokinetic parameters human volunteers explore effects chl chla cotreatment volunteers protocol num fasted subjects received institutional review board-approved dose num afb num ng num nci capsule num ml water normal eating drinking num hours blood cumulative urine samples collected num hours num afb num equivalents determined accelerator mass spectrometry protocols num num similar capsules contained num mg purified chla chl protocols repeated thrice volunteer study revealed rapid human afb num uptake plasma k a num num num t max num hour urinary elimination num complete num hours kinetics chla chl treatment significantly impeded afb num absorption reduced cmax aucs plasma urine subjects initial results provide afb num pharmacokinetic parameters previously unavailable humans suggest chla chl co-consumption limit bioavailability ingested aflatoxin humans animal models 
